Entering text into the input field will update the search result below

Baxter biopharma solutions unit seeing interest from Thermo Fisher, Celltrion - report

Mar. 20, 2023 9:43 PM ETBaxter International Inc. (BAX), TMOKKR, CGBy: Joshua Fineman, SA News Editor2 Comments

BioNTech To Expand Vaccine Production At Baxter International Facility

Sascha Schuermann/Getty Images News

  • Thermo Fisher (NYSE:TMO) and South Korea's Celltrion are competing for Baxter's (NYSE:BAX) Biopharma Solutions unit in a sale that could value the business at more than $4 billion.
  • Private equity firms including KKR (KKR

Recommended For You

Comments (2)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Why would anyone want their drugs manufactured and filled by KKR or Carlyle? Hope TMO passes.
Big Fat Dummy profile picture
So we’re chopping it up, I see…

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.